FIELD: chemistry.
SUBSTANCE: invention relates to a new derivative of sulfonamide substituted imidazoquinolines, and specifically to N-{2-[4-amino-2-(ethoxymethyl)-1H-imidazo-[4,5-c]-qunolin-1-yl]-1,1-dimethylethyl}-methanesulfonamide and its pharmaceutically acceptable salts, as well as to a pharmaceutical composition based on this compound.
EFFECT: invention also relates to a method of inducing biosynthesis of cytokines in an animal organism and methods of treating viral and oncological diseases in animals using said compound and pharmaceutical composition based on said compound.
5 cl, 1 tbl, 39 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMIDAZOQUINOLINES, PHARMACEUTICAL PREPARATION AND METHOD FOR INDUCTION OF CYTOKINE BIOSYNTHESIS BASED ON THEREOF | 2000 |
|
RU2248975C2 |
| THIOESTER-SUBSTITUTED IMIDAZOQUINOLINES AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2304143C2 |
| AMIDO-SUBSTITUTED IMIDAZOQUINOLINES | 2000 |
|
RU2295343C2 |
| ARYLETHER-SUBSTITUTED IMIDAZOQUINOLINES, PHARMACEUTICAL COMPOSITIONS BASED ON THE SAME, METHODS FOR TREATMENT OF VIRAL DISEASES BASED ON THE SAME AND METHODS FOR TREATMENT OF TUMOR DISEASE BASED ON THE SAME | 2001 |
|
RU2308456C2 |
| HETEROARYL COMPOUNDS, COMPOSITIONS CONTAINING THEM AND METHODS OF TREATING WITH USE OF SUCH COMPOUNDS | 2007 |
|
RU2478635C2 |
| THIOESTER-SUBSTITUTED IMIDAZOQUINOLINES | 2001 |
|
RU2315049C2 |
| SUBSTITUTED IMIDAZOQUINOLINES | 2018 |
|
RU2768629C2 |
| UREA-SUBSTITUTED IMIDAZOQUINOLINE ETHERS | 2001 |
|
RU2302418C2 |
| UREA-SUBSTITUTED IMIDAZOQUINOLINES, PHARMACEUTICAL PREPARATION AND METHOD FOR INDUCTION OF CYTOKINE BIOSYNTHESIS BASED ON THEREOF | 2000 |
|
RU2265020C2 |
| SUBSTITUTED IMIDAZOPYRIDINYL-AMINO-PYRIDINE COMPOUNDS, USEFUL FOR TREATMENT OF CANCER | 2010 |
|
RU2619463C2 |
